[Form 4] COLGATE PALMOLIVE CO Insider Trading Activity

Rhea-AI Filing Summary

Grant Shane, COO, Americas at Colgate-Palmolive Company, reported equity awards on 09/11/2025. The filing shows a grant of 3,569 restricted stock units (RSUs) that vest in equal one-third installments on each of the first three anniversaries of the grant. The report also records a stock option award for 24,712 shares with an exercise price of $84.06; the option vests in equal annual installments over three years beginning on the first anniversary of the grant and expires on 09/11/2033. After these transactions, the reporting person beneficially owns 94,119 common shares and holds 24,712 underlying shares from the option award.

Positive

• Time‑based vesting on both RSUs and options promotes executive retention over three years
• RSU award directly aligns the executive's interests with shareholders by granting 3,569 restricted shares
• Option grant provides upside participation with a clear exercise price of $84.06 and a defined expiration of 09/11/2033

Negative

• None.

Insights

Corporate Governance Expert

TL;DR: Executive received time‑vested equity awards to align pay with shareholder interests.

The Form 4 documents routine compensation grants: a restricted stock unit award and a stock option award. Vesting schedules spread over three years indicate retention intent. The disclosure is clear on quantities, vesting cadence and exercise price, enabling investors to model potential future dilution and incentive alignment. No other transactions or amendments are reported in this filing.

Executive Compensation Analyst

TL;DR: Mix of RSUs and options balances retention and performance upside for the executive.

The awards combine immediate share-value alignment via RSUs with leverage through options priced at $84.06 and exercisable over an eight-year contractual window. Equal annual vesting over three years for both instruments suggests standard retention-focused design. The filing provides the necessary mechanics to assess timing of potential share issuance and future exercised-for-share counts.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

GRANT SHANE

(Last) (First) (Middle)

C/O COLGATE-PALMOLIVE COMPANY

300 PARK AVENUE

(Street)

NEW YORK NY 10022

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
COLGATE PALMOLIVE CO [ CL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	COO, Americas

3. Date of Earliest Transaction (Month/Day/Year)
09/11/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/11/2025		A(1)		3,569	A	$0.0000	94,119	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$84.06	09/11/2025		A(2)		24,712		(3)	09/11/2033	Common Stock	24,712	$0.0000	24,712	D

Explanation of Responses:

1. Restricted stock unit award granted under the issuer's incentive compensation plan. The restricted stock unit award vests in equal 1/3 installments on each of the first, second and third anniversary of the date of grant.

2. Stock option award granted under the issuer's incentive compensation plan.

3. Option becomes exercisable in equal annual installments over three years beginning on the first anniversary of the September 11, 2025 grant date.

	/s/ Kristine Hutchinson, Attorney-in-Fact	09/12/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

Who filed this Form 4 for Colgate-Palmolive (CL)?

The reporting person is Grant Shane, COO, Americas, and the Form 4 was signed by an attorney-in-fact on behalf of the reporting person.

What equity awards were granted to Grant Shane on 09/11/2025?

He received 3,569 restricted stock units (RSUs) and a stock option for 24,712 shares with an exercise price of $84.06.

How do the RSU and option vesting schedules work?

The RSUs vest in three equal annual installments. The option becomes exercisable in equal annual installments over three years beginning on the first anniversary of 09/11/2025.

How many Colgate shares does the reporting person own after the transaction?

Following the reported transactions, the reporting person beneficially owns 94,119 common shares and holds 24,712 option‑underlying shares.

What is the expiration date of the option award?

The stock option expires on 09/11/2033.

Was this Form 4 filed individually or jointly?

The form indicates it was filed by one reporting person (individual filing).